6505--Emergency Breyanzi Infusion
Award Notice Posted
- Solicitation number
- 36C24825N0730
- Agency
-
Veterans Integrated Service Network 8
Veterans Health Administration, Department of Veterans Affairs
- Awarded
- to Bristol-Myers Squibb Company
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 36F79724D010136C24825N0730 Federal contract award
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8 awarded a contract (36F79724D0101) to Bristol-Myers Squibb Company for an emergency Breyanzi infusion, a specialized CAR T-cell therapy for treating relapsed or refractory large B-cell lymphoma. The contract, valued at $335,042.65 and issued on May 15, 2025, was processed through the Bay Pines VA Health Care System with an urgent procurement timeline driven by a patient scheduled for apheresis on May 23, 2025. Bristol-Myers Squibb was identified as the sole FDA-approved manufacturer capable of providing this specific medication, with extensive market research confirming no alternative vendors could meet the immediate medical need. The procurement was justified under FAR 8.405-6 due to the urgent and compelling nature of the patient's required treatment, with potential significant medical consequences if the medication were not promptly secured.
Notice text
Awarded contract 36F79724D010136C24825N0730 to Bristol-Myers Squibb Company for 335042.65 on 2025-05-15.
Files
| File | Type | Posted |
|---|---|---|
| LSJ Over SAT_Emergency Breyanzi Infusion_Redacted.pdf | ||
| 36F79724D0101 36C24825N0730_1.docx | DOCX document |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity